Medindia
Advertisement

Translational Health Science and Technology Institute, a India-MIT Venture

by Medindia Content Team on November 22, 2007 at 4:09 PM

Translational Health Science and Technology Institute, a India-MIT Venture
India's Department of Biotechnology is partnering the Massachusetts Institute of Technology (MIT) to set up a Translational Health Science and Technology Institute (THSTI) in India. The new institute, modelled after the Harvard-MIT Division of Health Sciences and Technology (HST), will include faculty from multiple disciplines and professions, according to a statement from MIT.

The institute will offer degrees through multidisciplinary programmes. Funded by the Indian government, THSTI will be a research and training centre connected to regional centres of excellence. It is expected to increase India's capacity for translating scientific and technological advancements into medical innovations that have the potential to improve healthcare both in India and around the world.
Advertisement

M.K. Bhan, secretary, Department of Biotechnology, and HST Director Martha Gray signed a letter of intent for this partnership here Monday. "This partnership is an opportunity to create a long term, synergistic relationship that will result in wide ranging benefits to global health," said Bhan.

HST will help recruit and train new THSTI faculty members. From September 2008 to 2011, four THSTI faculty members will join the HST faculty for a two-year training stint, during which they will develop translational research programmes and design courses and curricula for THSTI.
Advertisement

HST's success stories include medical innovations such as functional magnetic resonance imaging, a low-cost AIDS detection kit, and novel implantable drug delivery mechanisms.

Fifty years ago, MIT and India partnered to set up the Indian Institute of Technology (IIT) in Kanpur. "THSTI has the potential to be a second success story that could revolutionise medicine in India the same way the IIT revolutionised engineering and science," said Shiladitya Sengupta, assistant professor of medicine and an HST faculty member at Harvard Medical School.

Source: IANS
LIN/P
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Health Insurance - India 

Recommended Reading
India, US Signs Agreement to Develop Low-cost Medical Technologies
India and the US Thursday signed an agreement to develop low-cost medical technologies and share ......
Hi-Tech Diabetes Research Facility To Be Launched At Chennai
A state-of-the-art research centre will be set up by the Madras Diabetes Research Foundation ......
Health Insurance - India
Health insurance has emerged as one of the fastest growing segments in the non-life insurance indust...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use